Current Duke Appointments & Affiliations
Professor of Neurology
·
2018 - Present
Neurology, Neuromuscular Disease,
Neurology
Director of EMG Lab Services in the Department of Neurology
·
2006 - Present
Neurology,
Clinical Science Departments
Division Chief, Neuromuscular Disease in the Department of Neurology
·
2015 - Present
Neurology,
Clinical Science Departments
Recent Scholarly Works
The Duke MG Patient Registry III. Comparative Effectiveness of Azathioprine and Mycophenolate Mofetil in Generalized Myasthenia Gravis, a Retrospective Single Center Review.
Conference Muscle Nerve · May 2026 INTRODUCTION/AIMS: Azathioprine (AZA) and mycophenolate mofetil (MMF) are the most commonly used non-steroidal immunosuppressants in patients with generalized myasthenia gravis (gMG) in North America but their relative effectiveness among disease subgroups ... Full text Link to item CiteA Distinct Immunological Signature in Late-Onset Myasthenia Gravis: Insights from an Exploratory Proteomics Study.
Journal article Ann Neurol · January 2026 OBJECTIVE: Approximately 80% of patients with myasthenia gravis (MG) have autoantibodies against acetylcholine receptor, and clinical characteristics may vary between early-onset (symptom onset age <50 years) and late-onset MG (EOMG and LOMG), but the path ... Full text Link to item CiteMills' syndrome and myasthenia gravis: a case report.
Journal article Neuromuscul Disord · November 2025 A 50-year-old man with hypothyroidism was referred for refractory myasthenia gravis (MG). He developed progressive, painless right-sided shoulder and leg weakness, dysphagia, and fatigable diplopia. Acetylcholine receptor (AChR) antibodies were positive. I ... Full text Link to item CiteRecent Grants
DNA11 Argenx 999-2-MG-2000 Platform Study ISA Protocol
Clinical TrialPrincipal Investigator · Awarded by Argenx BV · 2026 - 2036A Master Protocol for an Exploratory, Phase 2a, Proof-of-Concept Platform Study to Evaluate the Safety, Tolerability, and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
Clinical TrialPrincipal Investigator · Awarded by Argenx BV · 2026 - 2035Capture MG
ResearchPrincipal Investigator · Awarded by The George Washington University · 2025 - 2030View All Grants
Education
University of Illinois ·
1989
M.D.